per million using residual solvent protons (1H NMR, δH = 7.26 for
CDCl3 and δH = 2.50 for DMSO-d6; 13C NMR, δC = 77.0 for CDCl3
and δC = 39.43 for DMSO-d6) as the internal standard. The splitting
patterns were designated as follows: s (singlet), d (doublet), t (triplet),
q (quartet), and m (multiplet). The assignments were Ph-H (phenyl
protons), CHO (aldehyde protons), Th-H (thiophene protons), BTDA-H
(benzothiadiazole protons), HexOPh-H (4-hexyloxyphenyl protons).
Melting points were determined using a Büchi B-545 apparatus and
were not corrected. Elemental analyses were performed on an Elementar
VarioEL. Thin layer chromatography was carried out on aluminum
plates, precoated with silica gel, Merck Si60 F254. Preparative column
chromatography was performed on glass columns packed with silica gel,
Merck Silica 60, particle size 40−63 μm. EI mass spectra were recorded
on a Varian Saturn 2000 GC-MS, CI mass spectra on a Finnigan MAT
SSQ-7000 and matrix-assisted laser desorption ionization time-of-flight
(MALDI-TOF) mass spectra on a Bruker Daltonics Reflex III.
Materials: Tetrahydrofuran (THF) (Merck) was dried under reflux over
sodium/benzophenone (Merck). dichloromethane (CH2Cl2), chloroform
(CHCl3), n-hexane, ethyl acetate, acetonitrile (MeCN), dioxane, and
methanol (MeOH) were purchased from Merck and distilled prior to
use. All synthetic steps were carried out under an argon atmosphere
(except Knoevenagel condensations). 2-Isopropoxy-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane was purchased from Aldrich and was dried over
molecular sieve (4 Å) prior to use. Ammonium acetate (NH4OAc) and
potassium carbonate were purchased from Merck, Pd2(dba)3·CHCl3,
Pd(PPh3)2Cl2, HPtBu3BF4, n-BuLi (1.6 mol L−1 in hexane) were purchased
from Acros, and cyanoacetic acid was purchased from ABCR. The
potassium phosphate (K3PO4) solution was prepared by dissolving
potassium phosphate (ABCR) in deionized water and was degassed
prior to use. 4-Bromo-N,N-bis[4-(hexyloxy)phenyl]aniline 3,[20] 4-bromo-
7-(bromomethyl)benzo[c][1,2,5]-thiadiazole 7,[21] 2,2′-bithiophene,[22]
and 4-(7-bromobenzo[c][1,2,5]thiadiazol-4-yl)benzaldehyde 10[23] were
prepared according to literature procedures.
6.6 Hz, 4H, -OCH2-), 1.72–1.65 (m, 4H, -OCH2CH2-), 1.44–1.36 (m, 4H,
3
-OCH2CH2CH2-), 1.32–1.27 (m, 8H, -CH2CH2CH3), 0.87 (t, J = 7.0 Hz,
6H, -CH3).13C NMR (100 MHz, DMSO-d6): δ = 155.41, 148.10, 142.50,
139.52, 136.56, 134.22, 128.30, 126.84, 126.04, 125.05, 124.98, 124.79,
123.60, 122.84, 119.12, 115.48, 67.63, 30.98, 28.69, 25.19, 22.05, 13.88.
MS (MALDI-TOF): m/z: [M+] 609.6 (calcd. for C38H43NO2S2 609.3).
Elemental analysis: calc. (%) for C38H43NO2S2: C, 74.84; H, 7.11; N,
2.30; found: C, 74.70; H, 7.09; N, 2.27.
5-(N,N-Bis(4-hexyloxyphenyl)-4-aminophenyl)-5′-(tri-n-butylstannyl)-2,2′-
bithiophene (6): Bithiophene 5 (601 mg, 0.99 mmol) was dissolved in
dry THF (10 mL) and the solution was cooled to –78 °C. n-BuLi (1.6 m
in hexane, 0.63 mL, 1.01 mmol) was added dropwise and the solution
turned dark green. It was stirred for 1 h at this temperature, then
tributyltin chloride (360 mg, 1.06 mmol) was added. The reaction mixture
was allowed to slowly warm to r.t. and was stirred at r.t. overnight. Water
(30 mL) was added and the mixture was extracted with dichloromethane
(DCM) (2 × 30 mL). The combined organic layers were washed with
water, dried over Na2SO4, and the solvent was removed. The crude
stannyl compound 6 (943 mg, quant.) was obtained as a brownish oil. It
1
was directly used in the next step without further purification. H NMR
(400 MHz, CDCl3): δ = 7.39 (d, 3J = 8.8 Hz, 2H, Ph-H), 7.28 (d, 3J = 3.2 Hz,
1H, Th-H), 7.10 (d, 3J = 4.0 Hz, 1H, Th-H), 7.08–7.04 (m, 6H, HexOPh-H
3
+ ThH), 6.91 (d, J = 8.8 Hz, 2H, Ph-H), 6.85–6.81 (m, 4H, HexOPh-H),
3.94 (t, 3J = 6.4 Hz, 4H, -OCH2-), 1.82–1.75 (m, 4H, -OCH2CH2-),
1.63–1.55 (m, 6H, -CH2-), 1.51–1.45 (m, 4H, CH2-), 1.43–1.31 (m, 14H,
-CH2-), 1.15–1.10 (m, 6H, -CH2-), 0.92 (t, 3J = 7.2 Hz, 6H, -CH3), 0.91 (t,
3J = 7.2 Hz, 9H, -CH3). 13C NMR (100 MHz, CDCl3): δ = 155.62, 148.30,
143.10, 143.08, 140.48, 136.30, 136.11, 135.60, 126.71, 126.60, 126.24,
126.18, 124.47, 124.30, 122.22, 120.46, 115.33, 68.31, 31.63, 29.36,
28.97, 27.27, 25.79, 22.63, 14.05, 13.67, 10.92. MS (MALDI-TOF): m/z:
[M+] 899.5 (calcd. for C50H69NO2S2Sn 899.4).
4-Bromo-7-(hydroxymethyl)benzo[c][1,2,5]thiadiazole (8): 4-Bromo-7-
(bromomethyl)-benzo[c][1,2,5]thiadiazole 7 (2.67 g, 8.67 mmol) and
potassium carbonate (3.60 g, 26.0 mmol) were suspended in a dioxane/
water mixture (50 mL, 1:1 v/v) and the mixture was refluxed for 1 h. The
solvents were removed in vacuo and the residue was partitioned between
2-(2,2′-Bithien-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (4): 2,2′-
Bithiophene (2.00 g, 12.0 mmol) was dissolved under argon in dry THF
(30 mL). At –78 °C, n-butyllithium (1.6 m in hexane, 7.52 mL, 12.0 mmol)
was added dropwise within 20 min. The greenish solution was allowed
to warm to r.t. within 75 min. 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.50 mL, 12.3 mmol) was slowly added at –78 °C,
the solution was allowed to warm to r.t. within 2 h and was stirred at
r.t. for 6 h. The reaction mixture was poured into a saturated NH4Cl
solution (30 mL) and was extracted with diethyl ether (3 × 30 mL). The
combined organic phases were washed with water, dried over Na2SO4,
and the solvent was evaporated to provide boronic ester 4 as viscous oil
(3.31 g, 94%). The product was dried in high vacuum and directly used
in the next step without further purification. 1H NMR (400 MHz, CDCl3):
2
m hydrochloric acid (60 mL) and dichloromethane (60 mL). The
aqueous phase was extracted with DCM (2 × 50 mL) and the combined
organic phases were dried over Na2SO4. Removal of the solvent afforded
2.13 g of crude product. It was purified by column chromatography
(silica; hexane/ethyl acetate 4:1). Product 8 was obtained as an off-white
powder (1.36 g, 5.57 mmol, 64%). Mp. 139 °C. 1H NMR (400 MHz,
CDCl3): δ = 7.82 (d, 3J = 7.2 Hz, 1H, BTDA-H-5), 7.47 (dt, 3J = 7.2 Hz, 4J
4
= 1.0 Hz, 1H, BTDA-H-6), 5.13 (d, J = 1.0 Hz, 2H, CH2OH), 2.52 (s br,
1H, CH2OH). 13C NMR (100 MHz, CDCl3): δ = 153.47, 153.08, 133.27,
132.01, 126.94, 113.21, 61.82. MS (CI): m/z (%): 247 ([M+]+2, 94), 245
([M+]+H, 100), 229 (87), 227(83), 217(18), 215(18). Elemental analysis:
calc. (%) for C7H5BrN2OS: C, 34.30; H, 2.06; N, 11.43; found: C, 34.55;
H, 2.22; N, 11.30.
3
δ = 7.55 (d, J = 3.6 Hz, 1H, Th-H), 7.28–7.24 (m, 3H, Th-H), 7.05–7.02
(m, 1H, Th-H), 1.38 (s, 12H, -CH3). 13C NMR (100 MHz, CDCl3): δ =
144.01, 137.88, 137.26, 127.86, 124.93, 124.91, 124.33, 124.31, 84.14,
24.74. MS (EI): m/z (%): 292 (M+, 100).
7-Bromobenzo[c][1,2,5]thiadiazole-4-carbaldehyde (9): 4-Bromo-7-
(hydroxy-methyl)benzo[c][1,2,5]thiadiazole 8 (1.00 g, 4.08 mmol) and
manganese(IV) oxide (1.43 g, 16.4 mmol) were suspended in chloroform
(40 mL) and the mixture was first stirred at r.t. for 16 h then refluxed
for 3 h. The mixture was filtered, the filtrate was evaporated, and the
residue was purified by column chromatography (silica; hexane/ethyl
acetate 4:1). The pure aldehyde 9 (884 mg, 89%) was obtained as a
slightly yellowish solid. Mp. 192 °C. 1H NMR (400 MHz, CDCl3): δ =
5-(N,N-Bis(4-hexyloxyphenyl)-4-aminophenyl)-2,2′-bithiophene (5): Trip-
henylamine 3 (834 mg, 1.59 mmol) and boronic ester 4 (550 mg,
1.88 mmol) were dissolved under argon in dry THF (12 mL) and the
solution was degassed. Pd2(dba)3 (29.8 mg, 32.5 μmol, 2 mol%) and
HPtBu3BF4 (18.6 mg, 62.2 μmol, 4 mol%) were added, and the solution
was degassed again. An aqueous solution of K3PO4 (2 m, 3.2 mL,
6.4 mmol) was added and the mixture turned from dark red to green.
It was stirred at r.t. overnight. The reaction mixture was poured into
a saturated NH4Cl solution (15 mL) and extracted with DCM (3 ×
15 mL). The combined organic phases were dried over Na2SO4 and the
solvent was removed in vacuo. The resulting brown oil was purified by
column chromatography (silica; hexane/DCM 9:1 to 6:4). Bithiophene 5
(930 mg, 96%) was obtained as a greenish yellow solid. Melting point
(Mp.) 61–64 °C.1H NMR (400 MHz, DMSO-d6): δ = 7.47 (dd, 3J = 5.2
Hz, 4J = 0.8 Hz, 1H, Th-H), 7.44 (m, 2H, Ph-H), 7.27 (dd, 3J = 3.6 Hz, 4J
= 1.2 Hz, 1H, Th-H), 7.26 (d, 3J = 3.6 Hz, 1H, Th-H), 7.23 (d, 3J = 3.6 Hz,
3
3
10.74 (s, 1H, CHO), 8.09 (d, J = 7.6 Hz, 1H, BTDA-H-5), 8.04 (d, J =
7.6 Hz, 1H, BTDA-H-6).13C NMR (100 MHz, CDCl3): δ = 188.34, 153.99,
152.28, 132.16, 131.68, 126.79, 121.89. MS (CI): m/z (%): 245 ([M+]+2,
100), 243 ([M+]+H, 99). Elemental analysis: calc. (%) for C7H3BrN2OS:
C, 34.59; H, 1.24; N, 11.52; found: C, 34.40; H, 1.26; N, 11.39.
7-(5-(N,N-Bis(4-hexyloxyphenyl)-4-aminophenyl)-2,2′-bithien-5′-yl)
benzo[c]-[1,2,5]thiadiazole-4-carbaldehyde (11): In a Schlenk tube, stannyl
compound
6 (805 mg, 0.716 mmol) and 7-bromobenzo[c][1,2,5]
thiadiazole-4-carbaldehyde 9 (148 mg, 0.609 mmol) were dissolved under
argon in dry THF (15 mL) and the solution was degassed. Pd(PPh3)2Cl2
(13.0 mg, 18.5 μmol, 3 mol%) was added and the solution was degassed
3
4
1H, Th-H), 7.07 (dd, J = 5.2 Hz, J = 3.6 Hz, 1H, Th-H), 7.01 (m, 4H,
3
HexOPh-H), 6.89 (m, 4H, HexOPh-H), 6.75 (m, 2H, Ph-H), 3.92 (t, J =
©
Adv. Funct. Mater. 2012, 22, 1291–1302
2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
1299